Research Catalog

FDA oversight : hearing before the Subcommittee on Health Care and Financial Services of the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.

Title
FDA oversight : hearing before the Subcommittee on Health Care and Financial Services of the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.
Author
United States. Congress. House. Committee on Oversight and Accountability. Subcommittee on Health Care and Financial Services, author.
Publication
Washington : U.S. Government Publishing Office, 2023.

Available Online

https://purl.fdlp.gov/GPO/gpo212601

Details

Description
1 online resource (volumes)
Alternative Title
Food and Drug Administration oversight
Subject
  • United States. Food and Drug Administration
  • Infant formulas > United States
  • Business logistics > United States
  • Congress
  • Government Operations and Politics
Genre/Form
Legislative hearings.
Note
  • "March 28, 2023"--Pt. 1.
  • "May 11, 2023"--Pt. 2.
  • In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
  • "Serial no. 118-13"--Pt. 1.
  • "Serial no. 118-31"--Pt. 2.
Bibliography (note)
  • Includes bibliographical references.
Event (note)
  • "Date of hearing: 2023-03-28"--Pt. 1.
  • "Date of hearing: 2023-05-11"--Pt. 2.
Source of Description (note)
  • Description based on online resource; title from PDF title page, pt. 1 (GovInfo, viewed May 18, 2023).
Contents
Pt. 1. Infant formula shortage -- Pt. 2. Responsibility for the infant formula shortage.
Call Number
GPO Internet Y 4.OV 2:118-13
LCCN
  • 51-718
  • 52-165
OCLC
marcive1379293534
Author
United States. Congress. House. Committee on Oversight and Accountability. Subcommittee on Health Care and Financial Services, author.
Title
FDA oversight : hearing before the Subcommittee on Health Care and Financial Services of the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.
Publisher
Washington : U.S. Government Publishing Office, 2023.
Type of Content
text
Type of Medium
computer
Type of Carrier
online resource
Bibliography
Includes bibliographical references.
Performer
"Hearing witnesses: Mr. Frank Yiannas, M.P.H., Former Deputy Commissioner, Office of Food Policy & Response, U.S. Food & Drug Administration; Dr. Peter Lurie, M.D., M.P.H. (Minority Witness), President & Executive Director, Center for Science in the Public Interest"--Pt. 1.
"5110 Hearing witnesses: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration"--Pt. 2.
Event
"Date of hearing: 2023-03-28"--Pt. 1.
"Date of hearing: 2023-05-11"--Pt. 2.
Connect to:
https://purl.fdlp.gov/GPO/gpo212601
Other Form:
Print version: United States. Congress. House. Committee on Oversight and Accountability. FDA oversight (OCoLC)1379292379
Other Standard Identifier
51-718 (GPO jacket number ; pt. 1)
52-165 (GPO jacket number ; pt. 2)
Gpo Item No.
1016-C (online)
Sudoc No.
Y 4.OV 2:118-31
Y 4.OV 2:118-13
View in Legacy Catalog